Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 11.59 AUD -0.34% Market Closed
Market Cap: 580.9m AUD

Intrinsic Value

The intrinsic value of one CUV stock under the Base Case scenario is 14.94 AUD. Compared to the current market price of 11.59 AUD, Clinuvel Pharmaceuticals Ltd is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CUV Intrinsic Value
14.94 AUD
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Clinuvel Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CUV
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CUV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Clinuvel Pharmaceuticals Ltd
ASX:CUV
AU
Biotechnology
Market Cap
580.2m AUD
IPO
Feb 13, 2001
AU
Biotechnology
Market Cap
580.2m AUD
IPO
Feb 13, 2001
Price
AU$false
EPS
AU$false
AI Assistant
AI Assistant
Ask me anything about Clinuvel Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Clinuvel Pharmaceuticals Ltd

Current Assets 227.6m
Cash & Short-Term Investments 198.2m
Receivables 16.3m
Other Current Assets 13.1m
Non-Current Assets 8.6m
PP&E 7.1m
Intangibles 185k
Other Non-Current Assets 1.3m
Efficiency

Free Cash Flow Analysis
Clinuvel Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Clinuvel Pharmaceuticals Ltd

Revenue
95.4m AUD
Cost of Revenue
-3.2m AUD
Gross Profit
92.2m AUD
Operating Expenses
-36.9m AUD
Operating Income
55.3m AUD
Other Expenses
-16.5m AUD
Net Income
38.8m AUD
Fundamental Scores

CUV Profitability Score
Profitability Due Diligence

Clinuvel Pharmaceuticals Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
76/100
Profitability
Score

Clinuvel Pharmaceuticals Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

CUV Solvency Score
Solvency Due Diligence

Clinuvel Pharmaceuticals Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Clinuvel Pharmaceuticals Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CUV Price Targets Summary
Clinuvel Pharmaceuticals Ltd

Wall Street analysts forecast CUV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CUV is 26.47 AUD with a low forecast of 15.15 AUD and a high forecast of 41.42 AUD.

Lowest
Price Target
15.15 AUD
31% Upside
Average
Price Target
26.47 AUD
128% Upside
Highest
Price Target
41.42 AUD
257% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CUV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CUV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CUV stock?

The intrinsic value of one CUV stock under the Base Case scenario is 14.94 AUD.

Is CUV stock undervalued or overvalued?

Compared to the current market price of 11.59 AUD, Clinuvel Pharmaceuticals Ltd is Undervalued by 22%.

Back to Top